BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Immunomedics, Inc. 

300 American Road

Morris Plains  New Jersey  07950-2450  U.S.A.
Phone: 201-605-8200 Fax: 973-605-8282


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Immunomedics, Inc. (IMMU) To Ring Opening Bell And Host R&D Day At The NASDAQ Stock Market 4/10/2014 7:41:29 AM    More...
Immunomedics, Inc. (IMMU) Reports Preclinical Results On SN-38 Antibody-Drug Conjugates As A Potential Novel Platform For Treating Cancer 4/8/2014 7:29:17 AM    More...
Immunomedics, Inc. (IMMU) To Provide Clinical Trial Updates On Solid-Tumor Antibody-Drug Conjugates At Cancer Conference 3/31/2014 9:20:23 AM    More...
Girard Gibbs Announces Class Action Lawsuit On Behalf Of Investors Of Immunomedics, Inc. (IMMU) 3/3/2014 8:50:59 AM    More...
Immunomedics, Inc. (IMMU) Extends Patent Life On Therapeutic Antibodies 2/27/2014 9:38:22 AM    More...
Immunomedics, Inc. (IMMU) To Present At Cowen And Company 34th Annual Health Care Conference 2/26/2014 9:00:15 AM    More...
Immunomedics, Inc. (IMMU) Announces Conference Call And Webcast For Second Quarter Fiscal 2014 Financial Results 2/7/2014 9:08:51 AM    More...
Immunomedics, Inc. (IMMU) Ranks 4th In The Patent Board Biotechnology Industry Scorecard 2/5/2014 9:32:51 AM    More...
Immunomedics, Inc. (IMMU) Announces Initiation Of Phase 3 Clinical Trial Of Clivatuzumab Tetraxetan In Patients With Pancreatic Cancer 1/10/2014 9:25:41 AM    More...
Immunomedics, Inc. (IMMU) Announces U.S. Patent For Antibody-SN-38 Conjugates 12/31/2013 9:10:41 AM    More...
12345678910...